Clinical Trial Update: SRS (Stereotactic Radiosurgery) Plus Ipilimumab [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating stereotactic radiosurgery (SRS) plus ipilimumab for newly diagnosed melanoma metastases in the brain and spine was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma with Brain Metastases
• Malignant Melanoma with Spinal Metastases

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Newly Diagnosed Melanoma Metastases in the Brain and Spine | Phase 1 | Status: TERMINATED